Preliminary safety, efficacy and immunogenicity results from a phase 1/2a study (DIRECT-01) of cancer neoantigen DNA vaccine VB10.NEO in patients with locally advanced or metastatic solid tumors
Zeitschriftentitel:
J Immunother Cancer
Jahr:
2019
Band / Volume:
7 Suppl 1
TUM Einrichtung:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)